TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study.

Front Immunol · 2026 · PMC13143888 · PMID 42099657

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Specifically, increases in helper T cells and natural killer cells were also significantly greater in patients who successfully underwent surgical conversion compared with those who did not ( Figure 2F ), whereas changes in cytotoxic T cells did not reach statistical significance between surgical and non-surgical groups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.